Jeliazko I. Arabadjiev
1407, Bulgaria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Prevalence of Homologous Recombination Deficiency and Treatment Patterns in Patients with Newly Diagnosed Advanced Ovarian Cancer in Bulgaria: A Real-World Cohort Study (VALIDATE).
Journal: Medicina (Kaunas, Lithuania)
Published: March 05, 2026
Real-world evidence of first-line osimertinib effectiveness in Bulgarian patients: a retrospective analysis.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: July 16, 2025
Impact of patient and tumor characteristics on various aspects of the non-small cell lung cancer patient journey in Romania, Bulgaria, Serbia: A multicenter, non-interventional, retrospective cohort study.
Journal: Cancer treatment and research communications
Published: January 22, 2025
Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first-line setting.
Journal: Cancer reports (Hoboken, N.J.)
Published: August 02, 2023
Engaging European society at the forefront of cancer research and care: How discussions at the 5th Gago Conference on European Science policy led to the Heidelberg Manifesto
Journal: Molecular oncology
Published: March 17, 2023
Alteration of Mesenchymal Stem Cells Isolated from Glioblastoma Multiforme under the Influence of Photodynamic Treatment.
Journal: Current issues in molecular biology
Published: February 10, 2023
Successful treatment with docetaxel plus nintedanib in a patient with lung adenocarcinoma and pulmonary fibrosis: A case report and literature review.
Journal: Frontiers in oncology
Published: March 29, 2022
Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer.
Journal: Bioscience trends
Published: February 06, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026